Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Botulinum toxin A helped stop hair loss and grow new hair in mice.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Acinetobacter strain A1-4-2 can safely clean water pollutants.

Arg1+ macrophages may play a role in causing alopecia areata.

The AI model somewhat predicts lymph node status in melanoma patients using skin sample images.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The new model improves Alopecia Areata classification accuracy to 93.1%.

CD8 T cells need interferon gamma to cause Alopecia Areata.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

XEDAR triggers a specific signaling pathway in cells.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Upadacitinib may effectively treat alopecia areata without side effects.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Precise objectives can improve student achievement in health education.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Regenera Activa AMT effectively improves hair growth and reduces hair loss in androgenetic alopecia.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.